The global market for cardiovascular PACS is expected to reach $891 million by the year 2017, according to a new report from market research firm Global Industry Analysts (GIA).
Factors driving market growth include increasing incidence of cardiovascular diseases, a push toward increasing workflow efficiencies, and a gradual move of cardiology PACS toward wider integration with other modalities, the firm said. In addition, advances in imaging modalities such as MRI, CT, echocardiography, PET/CT, and SPECT in the area of cardiac imaging have created substantial demand for cardiovascular PACS.
The U.S. represents the largest regional market for cardiovascular PACS, with Europe at a distant second in terms of market revenues. Growth is forecast to come mainly from developing regions, including Asia-Pacific, GIA said.
